Unknown

Dataset Information

Visfatin is involved in promotion of colorectal carcinoma malignancy through an inducing EMT mechanism.


ABSTRACT: Increasing evidences suggested visfatin, a newly discovered obesity-induced adipocytokine, is involved in promotion of cancer malignancy and correlated with worse clinical prognosis. While its effects and mechanisms on progression of colorectal cancer (CRC) remain unclear. Our clinical data show that visfatin protein is over expressed, positive associated with lymph node metastasis, high-grade tumor, and poor prognosis in 87 CRC patients. The levels of plasma visfatin are significantly upregulated in Stage IV colon cancer. Visfatin can significantly promote the in vitro migration and invasion of CRC cells via induction epithelial mesenchymal transition (EMT). It can increase the expression and nuclear translocation of Snail, a key transcription factor in regulating EMT. While silencing of

SUBMITTER: Yang J 

PROVIDER: S-EPMC5078014 | biostudies-literature | 2016 May

REPOSITORIES: biostudies-literature